Asfar Sohail Azmi

23PUBLICATIONS
41CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesCancer cell biologyCancer diagnosisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Dec 15, 2025
Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma.

Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel

|Nov 27, 2025
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges.

Khalil Choucair, Hafsa Imtiaz, Md Hafiz Uddin

|Nov 27, 2025
An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors.

Khalil Choucair, Roupen Odabashian, Sushmita Nanja Reddy

|Jan 08, 2024
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis.

Sahar F Bannoura, Amro Aboukameel, Husain Yar Khan

|Nov 14, 2023
Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management.

Jessica Elderkin, Najeeb Al Hallak, Asfar S Azmi

|Sep 13, 2023
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers.

Husain Yar Khan, Misako Nagasaka, Amro Aboukameel

Pageof 4

Frequent Collaborators

8 joint publications

Mohammed H Uddin

7 joint publications

Husain Yar Khan

6 joint publications

Ramzi M Mohammad

5 joint publications

Steve Kim